Oxford BioDynamics (LON:OBD) Shares Up 1.1% – Should You Buy?

Oxford BioDynamics Plc (LON:OBD)’s share price shot up 1.1% during mid-day trading on Wednesday . The stock traded as high as GBX 0.21 and last traded at GBX 0.19. 2,140,388 shares traded hands during mid-day trading, a decline of 88% from the average session volume of 18,405,418 shares. The stock had previously closed at GBX 0.19.

Oxford BioDynamics Stock Performance

The stock’s fifty day moving average is GBX 0.25 and its two-hundred day moving average is GBX 0.29. The firm has a market capitalization of £8.24 million, a price-to-earnings ratio of -0.24 and a beta of 0.42. The company has a debt-to-equity ratio of 457.97, a quick ratio of 2.80 and a current ratio of 0.88.

About Oxford BioDynamics

Oxford BioDynamics Plc is a global biotechnology company, advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases.

Its flagship product is EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) for cancer, a predictive immune response profile for immuno-oncology (IO) checkpoint inhibitor treatments, launched in February 2022.

In March 2021, the Company launched its first commercial prognostic test, EpiSwitch® CST (Covid Severity Test) and the first commercially available microarray kit for high-resolution 3D genome profiling and biomarker discovery, EpiSwitch® Explorer Array Kit.